Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 81.04B | 86.01B | 95.92B | 92.77B | 75.73B | 62.75B |
Gross Profit | 21.16B | 18.07B | 14.52B | 14.26B | 11.73B | 15.37B |
EBITDA | 29.19B | 29.19B | 30.69B | 25.05B | 28.75B | 14.55B |
Net Income | 612.00M | 641.00M | 1.13B | 2.06B | 3.97B | -134.00M |
Balance Sheet | ||||||
Total Assets | 491.58B | 490.42B | 490.10B | 441.28B | 391.00B | 343.70B |
Cash, Cash Equivalents and Short-Term Investments | 12.44B | 20.18B | 16.89B | 21.96B | 19.66B | 15.42B |
Total Debt | 245.86B | 234.79B | 233.71B | 214.07B | 175.93B | 156.62B |
Total Liabilities | 332.65B | 325.04B | 321.85B | 299.39B | 256.26B | 221.05B |
Stockholders Equity | 45.27B | 45.98B | 45.78B | 43.75B | 46.35B | 35.84B |
Cash Flow | ||||||
Free Cash Flow | -2.17B | -3.43B | -1.63B | 1.45B | 984.26M | 4.56B |
Operating Cash Flow | 8.83B | 7.21B | 6.59B | 8.40B | 7.80B | 8.78B |
Investing Cash Flow | -28.79B | -20.09B | -2.59B | -27.57B | -18.62B | -1.19B |
Financing Cash Flow | 20.62B | 16.97B | -7.43B | 20.82B | 13.67B | -4.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | C$7.77B | 11.04 | 6.19% | 0.35% | -8.63% | -27.09% | |
68 Neutral | $17.51B | 11.66 | 10.43% | 3.82% | 9.93% | 1.68% | |
66 Neutral | $148.97B | 144.40 | 1.83% | 0.52% | -20.34% | -21.46% | |
― | $8.27B | 11.85 | 12.60% | 4.53% | ― | ― | |
― | $1.71B | 34.17 | 15.07% | 1.75% | ― | ― | |
― | $2.80B | ― | -301.45% | 0.83% | ― | ― | |
75 Outperform | C$139.28B | 41.74 | 26.64% | 2.64% | 554.20% | 37.48% |
Brookfield Corporation reported strong financial results for the second quarter of 2025, with a 13% increase in distributable earnings before realizations to $1.3 billion. The company announced a three-for-two stock split and highlighted over $55 billion in asset monetizations, enhancing its capital position to a record $177 billion. This positions Brookfield to capitalize on investment opportunities and deliver long-term returns to shareholders. The acquisition of Just Group is expected to significantly expand Brookfield’s insurance assets, further strengthening its market position.
The most recent analyst rating on (TSE:BN) stock is a Buy with a C$51.25 price target. To see the full list of analyst forecasts on Brookfield Corporation stock, see the TSE:BN Stock Forecast page.
Brookfield Corporation announced that the conversion of its Series 42 Preferred Shares into Series 43 Shares will not proceed as the number of shares tendered for conversion was below the required threshold. As a result, holders of Series 42 Shares will retain their current shares. This decision maintains the status quo for shareholders and reflects the company’s ongoing commitment to managing its capital structure effectively.
The most recent analyst rating on (TSE:BN) stock is a Buy with a C$50.50 price target. To see the full list of analyst forecasts on Brookfield Corporation stock, see the TSE:BN Stock Forecast page.